DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 967 filers reported holding DANAHER CORPORATION in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $181,127,000 | -7.4% | 804,723 | -8.6% | 0.37% | -9.7% |
Q4 2020 | $195,507,000 | -11.0% | 880,108 | -13.8% | 0.41% | -21.8% |
Q3 2020 | $219,751,000 | +15.3% | 1,020,530 | -5.3% | 0.53% | +6.9% |
Q2 2020 | $190,551,000 | +34.6% | 1,077,596 | +5.3% | 0.49% | +7.2% |
Q1 2020 | $141,596,000 | -44.0% | 1,023,015 | -37.9% | 0.46% | -26.6% |
Q4 2019 | $252,728,000 | -8.8% | 1,646,648 | -14.2% | 0.63% | -12.6% |
Q3 2019 | $277,256,000 | -4.7% | 1,919,654 | -5.7% | 0.72% | -0.4% |
Q2 2019 | $290,985,000 | -1.7% | 2,035,998 | -9.2% | 0.72% | -1.8% |
Q1 2019 | $295,998,000 | +36.7% | 2,242,073 | +6.8% | 0.73% | +19.6% |
Q4 2018 | $216,497,000 | +35.0% | 2,099,470 | +42.3% | 0.61% | +72.7% |
Q3 2018 | $160,335,000 | +6.8% | 1,475,564 | -3.0% | 0.36% | +2.3% |
Q2 2018 | $150,168,000 | +16.0% | 1,521,773 | +15.1% | 0.35% | +18.0% |
Q1 2018 | $129,401,000 | +4.4% | 1,321,632 | -1.0% | 0.29% | +6.9% |
Q4 2017 | $123,936,000 | +7.1% | 1,335,231 | -1.1% | 0.28% | +7.0% |
Q3 2017 | $115,760,000 | -1.3% | 1,349,498 | -2.9% | 0.26% | -0.4% |
Q2 2017 | $117,295,000 | -1.3% | 1,389,919 | +0.1% | 0.26% | +2.0% |
Q1 2017 | $118,815,000 | +7.5% | 1,389,166 | -2.2% | 0.25% | +4.5% |
Q4 2016 | $110,513,000 | -2.5% | 1,419,748 | -1.8% | 0.24% | +3.4% |
Q3 2016 | $113,304,000 | +27.2% | 1,445,386 | +63.9% | 0.23% | +24.5% |
Q2 2016 | $89,054,000 | -12.7% | 881,722 | -18.0% | 0.19% | -1.6% |
Q1 2016 | $101,987,000 | +135.7% | 1,075,127 | +130.8% | 0.19% | +172.9% |
Q4 2015 | $43,265,000 | +2.7% | 465,815 | -5.8% | 0.07% | +1.4% |
Q3 2015 | $42,142,000 | -2.1% | 494,565 | -1.6% | 0.07% | +13.1% |
Q2 2015 | $43,025,000 | +1.8% | 502,680 | +1.0% | 0.06% | +3.4% |
Q1 2015 | $42,258,000 | -2.9% | 497,730 | -1.9% | 0.06% | -1.7% |
Q4 2014 | $43,500,000 | +13.3% | 507,530 | +0.4% | 0.06% | +13.2% |
Q3 2014 | $38,394,000 | -10.5% | 505,313 | -7.3% | 0.05% | -15.9% |
Q2 2014 | $42,919,000 | -8.6% | 545,138 | -12.9% | 0.06% | -11.3% |
Q1 2014 | $46,935,000 | -2.5% | 625,798 | +0.4% | 0.07% | -7.8% |
Q4 2013 | $48,122,000 | +10.5% | 623,337 | -0.8% | 0.08% | -7.2% |
Q3 2013 | $43,543,000 | +5.2% | 628,144 | -3.9% | 0.08% | -3.5% |
Q2 2013 | $41,386,000 | – | 653,808 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |